DK2886A - Dopamin-beta-hydroxylaseinhibitorer - Google Patents

Dopamin-beta-hydroxylaseinhibitorer Download PDF

Info

Publication number
DK2886A
DK2886A DK2886A DK2886A DK2886A DK 2886 A DK2886 A DK 2886A DK 2886 A DK2886 A DK 2886A DK 2886 A DK2886 A DK 2886A DK 2886 A DK2886 A DK 2886A
Authority
DK
Denmark
Prior art keywords
alkyl
hydroxylase
dopamine beta
hydrogen
co2c1
Prior art date
Application number
DK2886A
Other languages
Danish (da)
English (en)
Other versions
DK2886D0 (da
Inventor
Carl Kaiser
Lawrence Ivan Kruse
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK2886D0 publication Critical patent/DK2886D0/da
Publication of DK2886A publication Critical patent/DK2886A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Enzymes And Modification Thereof (AREA)
DK2886A 1985-01-08 1986-01-03 Dopamin-beta-hydroxylaseinhibitorer DK2886A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/689,680 US4728741A (en) 1985-01-08 1985-01-08 1-substituted-2-mercapto benzimidazole compounds and intermediates

Publications (2)

Publication Number Publication Date
DK2886D0 DK2886D0 (da) 1986-01-03
DK2886A true DK2886A (da) 1986-07-09

Family

ID=24769487

Family Applications (1)

Application Number Title Priority Date Filing Date
DK2886A DK2886A (da) 1985-01-08 1986-01-03 Dopamin-beta-hydroxylaseinhibitorer

Country Status (12)

Country Link
US (1) US4728741A (de)
EP (1) EP0190817B1 (de)
JP (1) JPS61161267A (de)
AT (1) ATE56207T1 (de)
AU (2) AU588562B2 (de)
CA (1) CA1269668A (de)
DE (1) DE3673835D1 (de)
DK (1) DK2886A (de)
ES (1) ES8703844A1 (de)
GR (1) GR860018B (de)
PT (1) PT81786B (de)
ZA (1) ZA8665B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151176A (ja) * 1984-12-24 1986-07-09 Sumitomo Chem Co Ltd ベンズイミダゾール誘導体およびそれを有効成分とする殺虫、殺ダニ剤
JPS63101380A (ja) * 1986-10-17 1988-05-06 Zeria Shinyaku Kogyo Kk 新規な２−メルカプトベンズイミダゾ−ル誘導体、それらの製造法およびそれらを有効成分として含有する抗潰瘍剤
IT1226100B (it) * 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
WO1991012001A1 (en) * 1990-02-13 1991-08-22 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted benzyl element
US5106863A (en) * 1990-03-26 1992-04-21 Ortho Pharmaceutical Corporation Substituted imidazole and pyridine derivatives
EP0474109A1 (de) * 1990-09-03 1992-03-11 Richter Gedeon Vegyeszeti Gyar R.T. Neue 5-Benzyl-substituierte Benzimidazolin-2-Thion-Derivate und Verfahren zu ihrer Herstellung
GB9101448D0 (en) * 1991-01-23 1991-03-06 Cox John H Improved door assembly
TW300219B (de) * 1991-09-14 1997-03-11 Hoechst Ag
US6114532A (en) * 1998-02-03 2000-09-05 Boehringer Ingelheim Pharma Kg Bicyclic heterocycles, the preparation thereof, and their use as pharmaceuticals
EP1646614A4 (de) * 2003-07-01 2008-09-10 Merck & Co Inc Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie
DE102007037579B4 (de) * 2007-08-09 2012-05-16 Emc Microcollections Gmbh Neue Benzimidazol-2-yl-alkylamine und ihre Anwendung als mikrobizide Wirkstoffe
JOP20190049A1 (ar) * 2016-09-23 2019-03-20 Bial Portela & C? S A مثبطات دوبامين-b-هيدروكسيلاز

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL302847A (de) * 1963-01-10
DE1542886A1 (de) * 1966-10-04 1970-05-14 Bayer Ag Fungizide Mittel
BE732508A (de) * 1968-05-08 1969-10-16
DE2235093C2 (de) * 1972-07-18 1974-07-04 Bayer Ag, 5090 Leverkusen Korrosionsschutzmittel
FR2521141A1 (fr) * 1982-02-09 1983-08-12 Rhone Poulenc Agrochimie Nouveaux derives du cyano-2 benzimidazole, leur preparation et leur utilisation comme fongicides
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
AU604506B2 (en) * 1986-10-09 1990-12-20 Wellcome Foundation Limited, The 1-(substituted alkenyl) benzimidazole derivatives

Also Published As

Publication number Publication date
ATE56207T1 (de) 1990-09-15
US4728741A (en) 1988-03-01
PT81786B (pt) 1988-05-27
JPS61161267A (ja) 1986-07-21
CA1269668A (en) 1990-05-29
GR860018B (en) 1986-04-29
PT81786A (en) 1986-02-01
EP0190817B1 (de) 1990-09-05
ES8703844A1 (es) 1987-03-01
AU3788789A (en) 1989-10-19
ZA8665B (en) 1986-08-27
EP0190817A1 (de) 1986-08-13
ES550699A0 (es) 1987-03-01
DK2886D0 (da) 1986-01-03
AU588562B2 (en) 1989-09-21
DE3673835D1 (de) 1990-10-11
AU5180186A (en) 1986-07-17

Similar Documents

Publication Publication Date Title
ATE45731T1 (de) 3-substituierte 2-oxindole-1-carboxamide, als analgetische und antiinflammatorische mittel verwendet.
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DK2886D0 (da) Dopamin-beta-hydroxylaseinhibitorer
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
DK164164C (da) 2,4-diphenyl-1,3-dioxanderivater og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende derivaterne og disses anvendelse til fremstilling af det farmaceutiske middel
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
FI803202L (fi) Fosfonohydroxiaettiksyra foerfarande foer dess framstaellning och dess anvaendning saosom laekemedel
ES8706651A1 (es) Un procedimiento para preparar derivados de tetrazol.
SE8704240L (sv) Analgetiska preparat
FI885662A7 (fi) Ruokasuolan haittojen vähentämisaine
FI894068A0 (fi) Sulfonamider med tetrazolylrest, foerfarande foer deras tillverkning och laekemedel.
IT8547865A0 (it) Nuovi derivati della i,4-diidropiri dina,procedimento per la loro preparazione,e loro impiego come farmaci
DE69002027D1 (de) (3-diethylaminopropyl)-1-amino-5-methyldipyrido(4,3-b)(3,4-f)indoltrihydrochlorid.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment